Cargando…

Difference between the prevalence of symptoms of depression and anxiety in non-diabetic smokers and in patients with type 2 diabetes with and without nicotine dependence

BACKGROUND: Individuals with diabetes who are smokers have higher risks of cardiovascular disease, premature death, and microvascular complications. The present study aims to determine the prevalence of symptoms of depression and anxiety in smokers with type 2 diabetes mellitus (T2D) and to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Osme, Simone Franco, Ferreira, LudmillaDell’IsolaPelegriniMelo, Jorge, Mariana Tanus, de Souza Andréo, Juliana, Jorge, MariaLuizaMendonçaPereira, de Melo Costa Pinto, Rogério, Jorge, Miguel Tanús, Jorge, Paulo Tannús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502448/
https://www.ncbi.nlm.nih.gov/pubmed/22906025
http://dx.doi.org/10.1186/1758-5996-4-39
_version_ 1782250341143674880
author Osme, Simone Franco
Ferreira, LudmillaDell’IsolaPelegriniMelo
Jorge, Mariana Tanus
de Souza Andréo, Juliana
Jorge, MariaLuizaMendonçaPereira
de Melo Costa Pinto, Rogério
Jorge, Miguel Tanús
Jorge, Paulo Tannús
author_facet Osme, Simone Franco
Ferreira, LudmillaDell’IsolaPelegriniMelo
Jorge, Mariana Tanus
de Souza Andréo, Juliana
Jorge, MariaLuizaMendonçaPereira
de Melo Costa Pinto, Rogério
Jorge, Miguel Tanús
Jorge, Paulo Tannús
author_sort Osme, Simone Franco
collection PubMed
description BACKGROUND: Individuals with diabetes who are smokers have higher risks of cardiovascular disease, premature death, and microvascular complications. The present study aims to determine the prevalence of symptoms of depression and anxiety in smokers with type 2 diabetes mellitus (T2D) and to evaluate if the prevalence of symptoms of depression and anxiety differ between the three groups studied (patients with T2D who smoke; patients with T2D who do not smoke; smokers without T2D), and finally determine if the degree of nicotine dependence is related to symptoms of anxiety and depression in smokers (with or without T2D). METHODS: Three study groups were formed: 46 T2D smokers (DS), 46 T2D non-smokers (D), and 46 smokers without diabetes (S), totaling 138 participants. Hospital Anxiety and Depression (HAD) scale and Fagerström Test were applied. RESULTS: The prevalence of symptoms of depression and anxiety in smokers with T2D was 30.4% and 50%, respectively. There was no significant difference in the proportion of individuals with symptoms of anxiety (p = 0.072) or depression (p = 0.657) in the DS group compared to group D or S. Among male patients with T2D, the smokers had a higher prevalence of anxiety symptoms (19.6%) than non-smokers (4,3%) (p = 0,025). The prevalence of high nicotine dependence among smokers with and without T2D was 39.1% and 37.1%, respectively (p = 0.999). Fagerström scores showed no significant correlation with the scores obtained on the subscale of anxiety (p = 0,735) or depression (p = 0,364). CONCLUSIONS: The prevalence of depression and anxiety among smokers with and without diabetes and non-smokers T2D is similar. Among male individuals with T2D, the smokers have more symptoms of anxiety than the non-smokers. There is no difference in the prevalence of nicotine dependence among smokers with and without diabetes. The presence of symptoms of anxiety or depression is similar between patients who are dependent and not dependent on nicotine.
format Online
Article
Text
id pubmed-3502448
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35024482012-11-21 Difference between the prevalence of symptoms of depression and anxiety in non-diabetic smokers and in patients with type 2 diabetes with and without nicotine dependence Osme, Simone Franco Ferreira, LudmillaDell’IsolaPelegriniMelo Jorge, Mariana Tanus de Souza Andréo, Juliana Jorge, MariaLuizaMendonçaPereira de Melo Costa Pinto, Rogério Jorge, Miguel Tanús Jorge, Paulo Tannús Diabetol Metab Syndr Research BACKGROUND: Individuals with diabetes who are smokers have higher risks of cardiovascular disease, premature death, and microvascular complications. The present study aims to determine the prevalence of symptoms of depression and anxiety in smokers with type 2 diabetes mellitus (T2D) and to evaluate if the prevalence of symptoms of depression and anxiety differ between the three groups studied (patients with T2D who smoke; patients with T2D who do not smoke; smokers without T2D), and finally determine if the degree of nicotine dependence is related to symptoms of anxiety and depression in smokers (with or without T2D). METHODS: Three study groups were formed: 46 T2D smokers (DS), 46 T2D non-smokers (D), and 46 smokers without diabetes (S), totaling 138 participants. Hospital Anxiety and Depression (HAD) scale and Fagerström Test were applied. RESULTS: The prevalence of symptoms of depression and anxiety in smokers with T2D was 30.4% and 50%, respectively. There was no significant difference in the proportion of individuals with symptoms of anxiety (p = 0.072) or depression (p = 0.657) in the DS group compared to group D or S. Among male patients with T2D, the smokers had a higher prevalence of anxiety symptoms (19.6%) than non-smokers (4,3%) (p = 0,025). The prevalence of high nicotine dependence among smokers with and without T2D was 39.1% and 37.1%, respectively (p = 0.999). Fagerström scores showed no significant correlation with the scores obtained on the subscale of anxiety (p = 0,735) or depression (p = 0,364). CONCLUSIONS: The prevalence of depression and anxiety among smokers with and without diabetes and non-smokers T2D is similar. Among male individuals with T2D, the smokers have more symptoms of anxiety than the non-smokers. There is no difference in the prevalence of nicotine dependence among smokers with and without diabetes. The presence of symptoms of anxiety or depression is similar between patients who are dependent and not dependent on nicotine. BioMed Central 2012-08-21 /pmc/articles/PMC3502448/ /pubmed/22906025 http://dx.doi.org/10.1186/1758-5996-4-39 Text en Copyright ©2012 Osme et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Osme, Simone Franco
Ferreira, LudmillaDell’IsolaPelegriniMelo
Jorge, Mariana Tanus
de Souza Andréo, Juliana
Jorge, MariaLuizaMendonçaPereira
de Melo Costa Pinto, Rogério
Jorge, Miguel Tanús
Jorge, Paulo Tannús
Difference between the prevalence of symptoms of depression and anxiety in non-diabetic smokers and in patients with type 2 diabetes with and without nicotine dependence
title Difference between the prevalence of symptoms of depression and anxiety in non-diabetic smokers and in patients with type 2 diabetes with and without nicotine dependence
title_full Difference between the prevalence of symptoms of depression and anxiety in non-diabetic smokers and in patients with type 2 diabetes with and without nicotine dependence
title_fullStr Difference between the prevalence of symptoms of depression and anxiety in non-diabetic smokers and in patients with type 2 diabetes with and without nicotine dependence
title_full_unstemmed Difference between the prevalence of symptoms of depression and anxiety in non-diabetic smokers and in patients with type 2 diabetes with and without nicotine dependence
title_short Difference between the prevalence of symptoms of depression and anxiety in non-diabetic smokers and in patients with type 2 diabetes with and without nicotine dependence
title_sort difference between the prevalence of symptoms of depression and anxiety in non-diabetic smokers and in patients with type 2 diabetes with and without nicotine dependence
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502448/
https://www.ncbi.nlm.nih.gov/pubmed/22906025
http://dx.doi.org/10.1186/1758-5996-4-39
work_keys_str_mv AT osmesimonefranco differencebetweentheprevalenceofsymptomsofdepressionandanxietyinnondiabeticsmokersandinpatientswithtype2diabeteswithandwithoutnicotinedependence
AT ferreiraludmilladellisolapelegrinimelo differencebetweentheprevalenceofsymptomsofdepressionandanxietyinnondiabeticsmokersandinpatientswithtype2diabeteswithandwithoutnicotinedependence
AT jorgemarianatanus differencebetweentheprevalenceofsymptomsofdepressionandanxietyinnondiabeticsmokersandinpatientswithtype2diabeteswithandwithoutnicotinedependence
AT desouzaandreojuliana differencebetweentheprevalenceofsymptomsofdepressionandanxietyinnondiabeticsmokersandinpatientswithtype2diabeteswithandwithoutnicotinedependence
AT jorgemarialuizamendoncapereira differencebetweentheprevalenceofsymptomsofdepressionandanxietyinnondiabeticsmokersandinpatientswithtype2diabeteswithandwithoutnicotinedependence
AT demelocostapintorogerio differencebetweentheprevalenceofsymptomsofdepressionandanxietyinnondiabeticsmokersandinpatientswithtype2diabeteswithandwithoutnicotinedependence
AT jorgemigueltanus differencebetweentheprevalenceofsymptomsofdepressionandanxietyinnondiabeticsmokersandinpatientswithtype2diabeteswithandwithoutnicotinedependence
AT jorgepaulotannus differencebetweentheprevalenceofsymptomsofdepressionandanxietyinnondiabeticsmokersandinpatientswithtype2diabeteswithandwithoutnicotinedependence